Adjunctive Cannabidiol for Recovery From Opioid Study (NCT06940674)
Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)
🩺 Plain-English Summary (8th-Grade Level)
The long-term goal of the project is to determine whether cannabidiol (CBD) can reduce craving and relapse in individuals with opioid use disorder (OUD). The first phase of this project was an open cross-over design study in healthy individuals to confirm the safety and pharmacokinetic (PK) effects of CBD (BSPG CBD; Brains Bioceutical). The second phase was a double-blinded randomized controlled trial to determine whether CBD reduces craving and anxiety in individuals with OUD maintained on opioid agonist therapy. This phase 3 trial will determine whether CBD can serve as a potential adjunct treatment to reduce illicit opioid use in individuals with OUD maintained on opioid agonist therapy.
Who can join: Review the eligibility criteria below.
Location: Icahn School of Medicine at Mount Sinai — New York, New York
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Icahn School of Medicine at Mount Sinai — New York, New York
- CODA Treatment Recovery — Portland, Oregon
📞 Contact the Study Coordinator
Phone: (929) 923-3216
Email: Zoe.Spieler@mountsinai.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use Disorder (OUD)
- Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) — Little Rock, Arkansas
- Mindfulness Texting for Medication Adherence and Chronic Pain Management — Albuquerque, New Mexico
- Mapping Ibogaine Neural Dynamics in Opioid Use Disorder — Irvine, California
- MethaLoad Dose-Finding Study — Philadelphia, Pennsylvania
- Opioid Adherence and Support Through Innovative Texting Strategies — Albuquerque, New Mexico
Explore by condition: All Opioid Use Disorder (OUD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.